ReviewBone marrow transplantation2021

PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation.

Chong-Sheng Qian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.